Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression

Melanoma Research

Volumn 16, Issue 1, 2006, Pages 29-36

  Kuźbicki, Łukasz ^a   Sarnecka, Agnieszka ^a   Chwirot, Barbara W ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cyclooxygenase 2; Immunohistochemistry; Melanoma progression; Molecular marker

Indexed keywords

CYCLOOXYGENASE 2;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; MELANOMA; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYMOLOGY; LYMPH NODE; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PIGMENTED NEVUS; SKIN TUMOR;

CYCLOOXYGENASE 2; DISEASE PROGRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 33645456543     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000194430.77643.a0     Document Type: Article

References (45)

1. Kurumbail RG, Kiefer JR, Marnett LJ. Cyclooxygenase enzymes: catalysis and inhibition. Curr Opin Struct Biol 2001; 11:752-760.
2. Morita I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediators 2002; 68-69:165-175.
3. Tanabe T, Tohnai N. Cyclooxygenase isoenzymes and their gene structures and expression. Prostaglandins Other Lipid Mediators 2002; 68-69:95-114.
4. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271:33 157-33 160.
5. Harris RC. Cyclooxygenase-2 in the kidney. J Am Soc Nephrol 2000; 11:2387-2394.
6. Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 2003; 7:207-222.
7. Singh B, Lucci A. Role of cyclooxygenase-2 in breast cancer. J Surg Res 2002; 108:173-179.
8. Leong J, Hughens-Fulford M, Rakhlin N, Habib A, Maclouf J, Goldyne ME. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 1996; 224:79-87.
9. Goldyne ME. Cyclooxygenase isoforms in human skin. Prostaglandins Other Lipid Mediators 2000; 63:15-23.
10. Yamauchi T, Watanabe M, Kubota T, Hasegawa H, Ishii Y, Endo T, et al. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum 2002; 45:98-103.
11. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000; 456:545-553.
12. Knösel T, Yu Y, Stein U, Schwabe H, Schlüns K, Schlag PM, et al. Overexpression of cyclooxygenase-2 correlates with chromosomal gain at the cyclooxygenase-2 locus and decreased patient survival in advanced colorectal carcinomas. Dis Colon Rectum 2004; 47:70-77.
13. Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, et al. Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially hematogenous metastasis, of colorectal cancer. Br J Cancer 2000; 83:324-328.
14. Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, Yasumaru M, et al. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 2002; 62:1567-1572.
15. Ristimäki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002; 62:632-635.
16. Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 2004; 90:423-429.
17. Lim HY, Joo HJ, Choi JH, Yi JW, Yang MS, Cho DY, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000; 6:519-525.
18. Yu L-Z, Gao H-J, Bai J-F, Sun G, Zhao H-L, Sun L, et al. Expression of COX-2 proteins in gastric mucosal lesions. World J Gastroenterol 2004; 10:292-294.
19. Fang HY, Lin T-S, Lin J-P, Wu YC, Chow K-C, Wang L-S. Cyclooxygenase-2 in human non-small cell lung cancer. Eur J Surg Oncol 2003; 29:171-177.
20. Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res 2000; 6:2424-2430.
21. Shirahama T, Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001; 7:558-561.
22. Kömhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol 2000; 157:29-35.
23. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999; 59:991-994.
24. Maaser K, Däubler P, Barthel B, Heine B, von Lampe B, Stein H, et al. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis. Br J Cancer 2003; 88:1217-1222.
25. Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000; 6:1229-1238.
26. Li S, Miner K, Fannin R, Barrett JC, Davis BJ. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol Oncol 2004; 92:622-627.
27. Seo SS, Song YS, Kang D, Park IA, Bang YJ, Kang SB, et al. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Gynecol Oncol 2004; 92:927-935.
28. Chen Y-J, Wang L-S, Wang P-H, Lai C-R, Yen M-S, Ng H-T, et al. High cyclooxygenase expression in cervical adenocarcinomas. Gynecol Oncol 2003; 88:379-385.
29. Edwards J, Mukherjee R, Munro AF, Wells AC, Almushatat A, Bartlett JMS. H ER2 and COX2 expression in human prostate cancer. Eur J Cancer 2004; 40:50-55.
30. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999; 59:987-990.
31. Wun T, McKnight H, Tuscano JM. Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma. Leuk Res 2004; 28:179-190.
32. Koki AT, Khan NK, Woerner BM, Seibert K, Harmon JL, Dannenberg AJ, et al. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukot Essent Fatty Acids 2002; 66:13-18.
33. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000; 60:1306-1311.
34. Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, et al. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 2003; 63:586-592.
35. Kazanov D, Dvory-Sobol H, Pick M, Liberman E, Strier L, Choen-Noyman E, et al. Celecoxib but not rofecoxib inhibits the growth of transformed cells in vitro. Clin Cancer Res 2004; 10:267-271.
36. Mardini IA, FitzGerald GA. Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. Mol Intervent 2001; 1:30-38.
37. Denkert C, Köbel M, Berger S, Siegert A, Leclere A, Trefzer U, et al. Expression of cyclooxygenase 2 in human melanoma. Cancer Res 2001; 61:303-308.
38. Goulet A-C, Einsphar JG, Alberts DS, Beas A, Burk C, Bhattacharyya A, et al. Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression. Cancer Biol Ther 2003; 2:713-718.
39. Shi SR, Cote RJ, Liu C, Yu MC, Castelao JE, Ross RK, et al. A modified reduced-temperature antigen retrieval protocol effective for use with a polyclonal antibody to cyclooxygenase-2 (PG 27). Appl Immunohistochem Mol Morphol 2002; 10:368-373.
40. Hsu S-M, Soban E. Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 1982; 30:1079-1082.
41. Scopsi L, Larsson L-I. Increased sensitivity in peroxidase immunocytochemistry. A comparative study of a number of peroxidase visualization methods employing a model system. Histochemistry 1986; 84:221-230.
42. Nicolaou A, Estale SE, Tsatmali M, Herrero DP, Thody AJ. Prostaglandin production by melanocytic cells and the effect of α-melanocyte stimulating hormone. FEBS Lett 2003; 57:223-226.
43. Lu B, Makhija SK, Nettelbeck DM, Rivera AA, Wang M, Komarova S, et al. Evaluation of tumor-specific promoter activities in melanoma. Gene Ther 2005; 12:330-338.
44. Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Insa A, Fortea JM. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res 2005; 15:169-177.
45. Labrousse A-L, Ntayi C, Hornebeck W, Bernard P. Stromal reaction in cutaneous melanoma. Crit Rev Oncol Hematol 2004; 49:269-275.